ArticleFrontiers in surgery2025
22 years of Minimal Incision Vertical Endoscopic Lift: a journey in endoscopic facial rejuvenation.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Two Endoscopic Surgical Approaches to Facial Rejuvenation: A Longitudinal Study on Safety and Patient Satisfaction.Plastic and reconstructive surgery. Global open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Minimal Incision Vertical Endoscopic Lifting (MIVEL) is a minimally invasive facial rejuvenation technique that repositions tissues with minimal scarring, reduced recovery time, and long-lasting results, while achieving a natural appearance. This study aims to describe the updated MIVEL procedure, focusing on its evolution over 22 years and providing methodological details. This includes refining the indications, identifying key fixation points for reproducible results, and highlighting the long-term success of MIVEL as an effective approach for facial rejuvenation with minimal scarring and reduced complications. Methods: This retrospective analysis encompasses a comprehensive review of 784 patients who underwent MIVEL between 2001 and 2023. The MIVEL technique involves small incisions, endoscopic guidance, and vertical lifting to reposition facial tissues. Preoperative and postoperative photographs, patients' demographic data, and complication rates were analyzed. Included patients were those seeking facial rejuvenation without extensive skin excision and attending all follow-up visits up to at least one year postoperatively. Patients were categorized into three MIVEL groups (I, II, III) of dissection, based on their age and related aging signs. Results: The average age of patients was 50.5 years, with the majority falling in the MIVEL II group (53.1 years). MIVEL I was primarily performed on younger patients (21-35 years), while MIVEL III was reserved for those over 55 years. Adjunctive procedures, such as guided Superficial Enhanced Fat Fluid Injection (SEFFI), blepharoplasty, and neck lift, were commonly combined with the MIVEL procedure. The complication rates were low, with transient issues like neuropraxia and periocular ecchymosis being the most common. No cases of severe complications like skin necrosis or permanent nerve injury were reported. Discussion: MIVEL has proven to be a highly effective and well-tolerated technique for the rejuvenation of the upper and middle thirds of the face. Its minimally invasive nature reduces recovery times and minimal scarring while providing lasting and natural-looking results. The 22-year experience underscores the reliability and high patient satisfaction associated with MIVEL, making it a preferred choice for facial rejuvenation surgery. Future directions include further refining the technique and exploring its applicability to other facial and neck rejuvenation areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.